Literature DB >> 28356284

Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through a TLR4-TRIF-PI3K signaling pathway.

Bruns A Watts1, Thampi George1, Edward R Sherwood2, David W Good3,4.   

Abstract

Monophosphoryl lipid A (MPLA) is a detoxified derivative of LPS that induces tolerance to LPS and augments host resistance to bacterial infections. Previously, we demonstrated that LPS inhibits [Formula: see text] absorption in the medullary thick ascending limb (MTAL) through a basolateral Toll-like receptor 4 (TLR4)-myeloid differentiation factor 88 (MyD88)-ERK pathway. Here we examined whether pretreatment with MPLA would attenuate LPS inhibition. MTALs from rats were perfused in vitro with MPLA (1 µg/ml) in bath and lumen or bath alone for 2 h, and then LPS was added to (and MPLA removed from) the bath solution. Pretreatment with MPLA eliminated LPS-induced inhibition of [Formula: see text] absorption. In MTALs pretreated with MPLA plus a phosphatidylinositol 3-kinase (PI3K) or Akt inhibitor, LPS decreased [Formula: see text] absorption. MPLA increased Akt phosphorylation in dissected MTALs. The Akt activation was eliminated by a PI3K inhibitor and in MTALs from TLR4-/- or Toll/IL-1 receptor domain-containing adaptor-inducing IFN-β (TRIF)-/- mice. The effect of MPLA to prevent LPS inhibition of [Formula: see text] absorption also was TRIF dependent. Pretreatment with MPLA prevented LPS-induced ERK activation; this effect was dependent on PI3K. MPLA alone had no effect on [Formula: see text] absorption, and MPLA pretreatment did not prevent ERK-mediated inhibition of [Formula: see text] absorption by aldosterone, consistent with MPLA's low toxicity profile. These results demonstrate that pretreatment with MPLA prevents the effect of LPS to inhibit [Formula: see text] absorption in the MTAL. This protective effect is mediated directly through MPLA stimulation of a TLR4-TRIF-PI3K-Akt pathway that prevents LPS-induced ERK activation. These studies identify detoxified TLR4-based immunomodulators as novel potential therapeutic agents to prevent or treat renal tubule dysfunction in response to bacterial infections.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  LPS; Toll-like receptor 4; kidney; monophosphoryl lipid A; sepsis

Mesh:

Substances:

Year:  2017        PMID: 28356284      PMCID: PMC5538844          DOI: 10.1152/ajprenal.00064.2017

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  76 in total

1.  IRAK-M is a negative regulator of Toll-like receptor signaling.

Authors:  Koichi Kobayashi; Lorraine D Hernandez; Jorge E Galán; Charles A Janeway; Ruslan Medzhitov; Richard A Flavell
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

Review 2.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 3.  Pathophysiology of interleukin-1 receptor-associated kinase-M: implications in refractory state.

Authors:  Eduardo López-Collazo; Pablo Fuentes-Prior; Francisco Arnalich; Carlos del Fresno
Journal:  Curr Opin Infect Dis       Date:  2006-06       Impact factor: 4.915

4.  Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors.

Authors:  Craig W Lindsley; Zhijian Zhao; William H Leister; Ronald G Robinson; Stanley F Barnett; Deborah Defeo-Jones; Raymond E Jones; George D Hartman; Joel R Huff; Hans E Huber; Mark E Duggan
Journal:  Bioorg Med Chem Lett       Date:  2005-02-01       Impact factor: 2.823

Review 5.  Sepsis and the kidney.

Authors:  Jennifer Klenzak; Jonathan Himmelfarb
Journal:  Crit Care Clin       Date:  2005-04       Impact factor: 3.598

6.  Monophosphoryl lipid A protects against gram-positive sepsis and tumor necrosis factor.

Authors:  M E Astiz; A Galera; D C Saha; C Carpati; E C Rackow
Journal:  Shock       Date:  1994-10       Impact factor: 3.454

Review 7.  Molecular mechanisms of endotoxin tolerance.

Authors:  Hongkuan Fan; James A Cook
Journal:  J Endotoxin Res       Date:  2004

Review 8.  The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants.

Authors:  Julia K Bohannon; Antonio Hernandez; Perenlei Enkhbaatar; William L Adams; Edward R Sherwood
Journal:  Shock       Date:  2013-12       Impact factor: 3.454

9.  Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial.

Authors:  M E Astiz; E C Rackow; J G Still; S T Howell; A Cato; K B Von Eschen; J T Ulrich; J A Rudbach; G McMahon; R Vargas
Journal:  Crit Care Med       Date:  1995-01       Impact factor: 7.598

Review 10.  Pathophysiology of endotoxin tolerance: mechanisms and clinical consequences.

Authors:  Eduardo López-Collazo; Carlos del Fresno
Journal:  Crit Care       Date:  2013-11-14       Impact factor: 9.097

View more
  10 in total

1.  Monophosphoryl lipid A pretreatment suppresses sepsis- and LPS-induced proinflammatory cytokine production in the medullary thick ascending limb.

Authors:  Bruns A Watts; Esther Tamayo; Edward R Sherwood; David W Good
Journal:  Am J Physiol Renal Physiol       Date:  2020-05-18

2.  Monophosphoryl lipid A-induced activation of plasmacytoid dendritic cells enhances the anti-cancer effects of anti-PD-L1 antibodies.

Authors:  Wei Zhang; Seong-Min Lim; Juyoung Hwang; Srinivasan Ramalingam; Myunghee Kim; Jun-O Jin
Journal:  Cancer Immunol Immunother       Date:  2020-09-09       Impact factor: 6.968

3.  Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through induction of Tollip and negative regulation of IRAK-1.

Authors:  Bruns A Watts; Esther Tamayo; Edward R Sherwood; David W Good
Journal:  Am J Physiol Renal Physiol       Date:  2019-06-26

Review 4.  An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives.

Authors:  Alessio Facciolà; Giuseppa Visalli; Antonio Laganà; Angela Di Pietro
Journal:  Vaccines (Basel)       Date:  2022-05-22

5.  Monophosphoryl lipid A prevents impairment of medullary thick ascending limb [Formula: see text] absorption and improves plasma [Formula: see text] concentration in septic mice.

Authors:  Bruns A Watts; Thampi George; Edward R Sherwood; David W Good
Journal:  Am J Physiol Renal Physiol       Date:  2018-05-09

Review 6.  Innate Immune Memory and the Host Response to Infection.

Authors:  Edward R Sherwood; Katherine R Burelbach; Margaret A McBride; Cody L Stothers; Allison M Owen; Antonio Hernandez; Naeem K Patil; David L Williams; Julia K Bohannon
Journal:  J Immunol       Date:  2022-02-15       Impact factor: 5.422

7.  TRIF Regulates BIC/miR-155 via the ERK Signaling Pathway to Control the ox-LDL-Induced Macrophage Inflammatory Response.

Authors:  Yaxi Wu; Jinshan Ye; Ruiwei Guo; Xing Liang; Lixia Yang
Journal:  J Immunol Res       Date:  2018-06-07       Impact factor: 4.818

8.  Lipopolysaccharide directly inhibits bicarbonate absorption by the renal outer medullary collecting duct.

Authors:  Shuichi Tsuruoka; Jeffrey M Purkerson; George J Schwartz
Journal:  Sci Rep       Date:  2020-11-25       Impact factor: 4.379

9.  Development of Exhausted Memory Monocytes and Underlying Mechanisms.

Authors:  Kisha Pradhan; Ziyue Yi; Shuo Geng; Liwu Li
Journal:  Front Immunol       Date:  2021-10-28       Impact factor: 8.786

10.  Quo Vadis Anesthesiologist? The Value Proposition of Future Anesthesiologists Lies in Preserving or Restoring Presurgical Health after Surgical Insult.

Authors:  Krzysztof Laudanski
Journal:  J Clin Med       Date:  2022-02-21       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.